Pfizer’s COVID-19 antiviral pill will already have some competition in the US: The Food and Drug Administration has given emergency use authorization for Merck’s Molnupiravir pill.
FDA gives emergency authorization to Pfizer’s COVID-19 pill
COVID-19 patients as young as 12 are eligible for enzyme-inhibiting treatment.
Womp, womp: Efficacy of Merck’s Thor-inspired COVID pill crumbles, vexing experts
FDA advisers voted 13-to-10 in favor of authorization given risks and modest benefits.
Meet molnupiravir, Merck’s Thor-inspired pill that hammers COVID
In Phase III trial, the drug smashed hospitalization and death rate by about half.